Processa Pharmaceuticals Statistics
NASDAQ: PCSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.56-0.13 (-7.69%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Processa Pharmaceuticals by the numbers
Processa Pharmaceuticals has a market capitalization of $4.4 million based on 2.80M shares outstanding. With trailing EPS of $-68.29, Processa Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.1% below its 50-day average and 31.3% below its 200-day average.
Average daily trading volume is 79.50K shares, or about $124,020 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PCSA valuation vs. peer median
| Metric | PCSA | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.37M | $3.98M | +10% |
| Avg. volume | 79.50K | 73.20K | +9% |
Peer median across 8 companies: CANF, PULM, SCNX, BLRX, LTRN, ALZN, SILO, BGMS.
Valuation
- Market cap
- $4.37M
- EPS (TTM)
- $-68.29
- Shares outstanding
- 2.80M
Price and trading
- Previous close
- 1.69
- Open
- 1.64
- Day range
- 1.39 – 1.66
- 52-week range
- 1.04 – 8.88
- Beta
- —
- Volume
- 69.95K
- Average volume
- 79.50K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 4.37M
- Forward Pe
- -0.42
- Eps
- -68.29
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.88
- Week52 Low
- 1.04
- Avg Volume
- 79,500.00
- Shares Outstanding
- 2.80M
- Ma50
- 1.78
- Ma200
- 2.27
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -82.43%
- Pct From52w Low
- 49.86%